Back to User profile » Dr Lin Xu
Paper published by Dr Lin Xu:
Original Research
Low-Dose Versus Standard-Dose Bevacizumab Plus Sintilimab for Unresectable Hepatocellular Carcinoma: A Real-World Comparative Study of Efficacy and Safety
Xu L, Wang X, Lai X, Li A, Mao Y, Wang X, Wu J
Journal of Hepatocellular Carcinoma 2026, 13:582999
Published Date: 12 April 2026